Home / Pharmaceutical / The Pharmaceutical Market: Qatar

The Pharmaceutical Market: Qatar

Published: Jul 2014 | No Of Pages: 107 | Published By: Espicom

Product Synopsis

Qatar Pharmaceuticals & Healthcare Report
According to recent reports in The Gulf Times, Qatar will have four new drug manufacturers by the end of Q113. The drugmakers will reportedly import their raw materials and produce tablets, syrups and injectables. It is anticipated the drug manufacturers will (in our view eventually) help curb reliance on imports and lower prices of retail medicines in the country as a result of increased local competition, according to Dr Aisha al-Ansari of the Supreme Council of Health Pharmacy and Drug Control Department (SCH). If the production facilities are opened on schedule, we will revise our forecasts accordingly. Generally speaking, however, we expect Qatar to remain greatly reliant on imported medicines, given the high level of consumption of patented drugs.
Headline Expenditure Projections
  • Pharmaceuticals: QAR1.32bn (US$362mn) in 2011 to QAR1.38bn (US$379mn) in 2012; +4.7% in local currency and US dollar terms. Historical figures adjusted to reflect new import data.
  • Healthcare: QAR10.54bn (US$2.89bn) in 2011 to QAR11.40bn (US$3.13bn) in 2012; +8.2% in local currency and US dollar terms. Forecastslightly lower fromQ412on account of macroeconomic factors.
  • Medical devices: QAR1.02mn (US$279mn) in 2011 to QAR1.15mn (US$317mn) in 2012; +13.6% in local currency and US dollar terms. Forecastslightly lower fromQ412on account of macroeconomic factors.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Executive Summary5
SWOT Analysis7
Qatar Pharmaceuticals And Healthcare Industry SWOT7
Qatar Political SWOT8
Qatar Economic SWOT8
Qatar Business Environment SWOT9
Pharmaceutical Risk/Reward Ratings10
Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q11311
Qatar - Market Summary14
Regulatory Regime15
Regional Regulatory Developments16
FTA Agreements17
Intellectual Property Regime18
Pricing And Reimbursement Regime19
Drug Price Reform Failure19
Industry Developments21
Non-Communicable Diseases22
Communicable Diseases25
Healthcare Sector25
Regional Healthcare Sector Developments27
Healthcare Reform28
Health Insurance29
Healthcare IT30
Research & Development31
Clinical Trials33
Medical Devices Industry33
Recent Developments in the Medical Devices Industry34
Industry Forecast Scenario36
Pharmaceutical Market Forecast36
Table: Pharmaceutical Sales Indicators 2008-201638
Healthcare Market Forecast39
Table: Healthcare Expenditure Indicators 2008-201640
Table: Government Healthcare Indicators 2008-201640
Table: Private Healthcare Indicators 2008-201641
Key Growth Factors - Macroeconomic42
Prescription Drug Market Forecast47
Table: Prescription Drug Sales Indicators 2008-201648
Patented Drug Market Forecast49
Table: Patented Drug Market Indicators 2008-201650
Generic Drug Market Forecast51
Table: Generic Drug Sales Indicators 2008-201652
OTC Medicine Market Forecast53
Table: OTC Medicine Sales Indicators 2008-201654
Pharmaceutical Trade Forecast55
Table: Exports and Imports Indicators, 2008-201656
Medical Device Market Forecast57
Table: Medical Devices Sales Indicators 2008-201658
Other Healthcare Data59
Table: Healthcare Professionals (2009)60
Key Risks To BMI's Forecasts61
Competitive Landscape62
Pharmaceutical Industry62
Pharmacy Wholesale And Retail63
Company Profiles64
Local Companies64
Qatari German Company For Medical Devices (QGMD)64
Medicare Group66
Ebn Sina Medical67
Qatar Pharma68
Multinational Companies69
Merck & Co70
Demographic Outlook73
Table: Population By Age Group, 1990-2020 ('000)74
Table: Population By Age Group, 1990-2020 (% of total)74
Table: Key Population Ratios, 1990-202075
Table: Rural And Urban Population, 1990-202076
BMI Methodology79
How We Generate Our Pharmaceutical Industry Forecasts79
Pharmaceutical Risk/Reward Ratings Methodology80
Ratings Overview80
Table: Pharmaceutical Risk/Reward Indicators81
Table: Weighting Of Components82
Choose License Type
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +